A study for a 20 year old woman who takes Cefdinir, Junel 1/20 - from FDA reports


7 females aged 20 (±5) who take the same drugs are studied. This is a personalized study for a 20 year old female patient who has Upper Respiratory Tract Infection. The study is created by eHealthMe based on reports from FDA.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our independent and original studies have been referenced on 400+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO.



On Jun, 12, 2018

7 females aged 20 (±5) who take Cefdinir, Junel 1/20 are studied.


Number of reports submitted per year:

Cefdinir, Junel 1/20 for a 20-year old woman.

Information of the patient in this study:

  • Age: 20
  • Gender: female
  • Conditions: Upper Respiratory Tract Infection
  • Drugs taken:
    • Cefdinir (cefdinir)
    • Junel 1/20 (ethinyl estradiol; norethindrone acetate)

eHealthMe real world results:

Comparison with this patient's adverse outcomes:

  • Migraine(headache): 0 (0% of females aged 20 (±5) who take the drugs)

As an adverse outcome could be a symptom of a condition, additional studies are listed to help identify the cause: for example, regardless of which drug is taken, how many female HBP patients aged 50 (±5) have nausea

As an adverse outcome could be a side effect of a drug, additional studies are listed to help identify the cause: for example, how many female Aspirin users aged 50 (±5) have nausea

Most common drug interactions over time

< 1 month:
  1. Lip swelling
1 - 6 months:
n/a
6 - 12 months:
n/a
1 - 2 years:
n/a
2 - 5 years:
n/a
5 - 10 years:
n/a
10+ years:
n/a
not specified:
  1. Pulmonary embolism (blockage of the main artery of the lung)
  2. Abdominal pain
  3. Uterine perforation (accidental puncture of the uterus)
  4. Emotional distress
  5. Dehydration (dryness resulting from the removal of water)

Top conditions involved for these people *:

  1. Oral Contraception : 5 people, 71.43%
  2. Asthma : 5 people, 71.43%
  3. Colonoscopy : 1 person, 14.29%
  4. Attention Deficit Hyperactivity Disorder : 1 person, 14.29%
  5. Acne (skin problems that cause pimples): 1 person, 14.29%

Top co-used drugs for these people *:

  1. Zithromax (6 people, 85.71%)
  2. Flovent Hfa (5 people, 71.43%)
  3. Yasmin (5 people, 71.43%)
  4. Prednisone (5 people, 71.43%)
  5. Albuterol (5 people, 71.43%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Want to find out more about the FDA reports used in the study? You can request them from FDA.

You are not alone: Connect with people like you, or share your experience to help people like you.

What are the drugs?

What are the conditions?

What are the symtoms?

Could your drugs cause:

Could your conditions cause:



Related studies:

You may be interested in these posts

More posts for: Cefdinir, Junel 1/20, Upper respiratory tract infection, Migraine

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.